Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT (16, 58, 2023)
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Nagler, Arnon
- Labopin, Myriam
- Blaise, Didier
- Raiola, Anna Maria
- Corral, Lucia Lopez
- Bramanti, Stefania
- Sica, Simona
- Kwon, Mi
- Koc, Yener
- Pavlu, Jiri
- Kulagin, Alexander
- Busca, Alessandro
- Rodriguez, Arancha Bermudez
- Remenyi, Peter
- Schmid, Christoph
- Brissot, Eolia
- Bazarbachi, Ali
- Giebel, Sebastian
- Ciceri, Fabio
- Mohty, Mohamad
Grupos
Abstract
The original article [1] incorrectly presents Affiliation 7. The correct affiliation can be viewed ahead in this Correction article: 7Transplantation Unit Department of Oncology and Haematology, IRCCS Humanitas Research Hospital, Milan, Italy. © 2023, BioMed Central Ltd., part of Springer Nature.
Datos de la publicación
- ISSN/ISSNe:
- 1756-8722, 1756-8722
- Tipo:
- Correction
- Páginas:
- 106-106
- PubMed:
- 37775766
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 4,241 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Journal of Hematology & Oncology BMC
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- erratum
Campos de Estudio
Cita
Nagler A,Labopin M,Blaise D,Raiola AM,Corral LL,Bramanti S,Sica S,Kwon MI,Koc Y,Pavlu J,Kulagin A,Busca A,Rodriguez AB,Remenyi P,Schmid C,Brissot E,Sanz J,Bazarbachi A,Giebel S,Ciceri F,Mohty M. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT (16, 58, 2023). J. Hematol. Oncol. 2023. 16(1):p. 106-106. IF:29,900. (1).
Portal de investigación